Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat—II. Evidence for striataln-methyl-d-aspartate receptor regulation of striatonigral gabaergic transmission and motor function
暂无分享,去创建一个
[1] U. Ungerstedt,et al. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat—I. Effects of perfusion with tetrodotoxin and low-calcium medium , 1996, Neuroscience.
[2] L. Bianchi,et al. Differential regulation by N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors of acetylcholine release from the rat striatum in vivo , 1995, Neuroscience.
[3] A. Parent,et al. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.
[4] B. Fredholm,et al. Role of NMDA, AMPA and kainate receptors in mediating glutamate- and 4-AP-induced dopamine and acetylcholine release from rat striatal slices , 1994, Neuropharmacology.
[5] J. Desce,et al. Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes , 1994, Neurochemistry International.
[6] Micaela Morelli,et al. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.
[7] J. Walsh,et al. Synaptic activation of N-methyl-d-aspartate receptors induces short-term potentiation at excitatory synapses in the striatum of the rat , 1993, Neuroscience.
[8] M. Desban,et al. Local GABAergic regulation of the N-methyl-d-aspartate-evoked release of dopamine is more prominent in striosomes than in matrix of the rat striatum , 1993, Neuroscience.
[9] U. Ungerstedt,et al. N‐methyl‐d‐Aspartic Acid Differentially Regulates Extracellular Dopamine, GABA, and Glutamate Levels in the Dorsolateral Neostriatum of the Halothane‐Anesthetized Rat: An In Vivo Microdialysis Study , 1993, Journal of neurochemistry.
[10] D. Nicholls,et al. The glutamatergic nerve terminal. , 1993, European journal of biochemistry.
[11] K. Jhamandas,et al. Excitatory amino acid action on the release of brain neurotransmitters and neuromodulators: Biochemical studies , 1993, Progress in Neurobiology.
[12] A. Young,et al. N‐Methyl‐d‐Aspartate Releases γ‐Aminobutyric Acid from Rat Striatum In Vivo: A Microdialysis Study Using a Novel Preloading Method , 1993, Journal of neurochemistry.
[13] S. Hernández,et al. NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis , 1992, Brain Research.
[14] R. Albin,et al. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons , 1992, Brain Research.
[15] J. Desce,et al. Modulation of GABA release by α-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-d-aspartate receptors in matrix-enriched areas of the rat striatum , 1992, Neuroscience.
[16] R. Beninger,et al. N-Methyl-d-asparate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol , 1992, Brain Research.
[17] C. Gerfen. The neostriatal mosaic: multiple levels of compartmental organization , 1992, Trends in Neurosciences.
[18] J. Desce,et al. l-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-d-aspartate receptors , 1992, Neuroscience.
[19] E. Abercrombie,et al. Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input , 1992, Neuroscience.
[20] U. Ungerstedt,et al. The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo mirodialysis study , 1992, Brain Research.
[21] W. Hauber,et al. Behavioural pharmacology of glutamate in the basal ganglia. , 1992, Journal of neural transmission. Supplementum.
[22] J. Desce,et al. Specific role of n-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat , 1991, Neuroscience.
[23] Dan C. Martin,et al. Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine , 1991, Neuroscience Letters.
[24] James K. T. Wang,et al. Presynaptic Glutamate Receptors Modulate Dopamine Release from Striatal Synaptosomes , 1991, Journal of neurochemistry.
[25] A. Young,et al. N‐Methyl‐D‐Aspartate Releases Excitatory Amino Acids in Rat Corpus Striatum In Vivo , 1991, Journal of neurochemistry.
[26] J. Desce,et al. Glutamatergic Control of Dopamine Release in the Rat Striatum: Evidence for Presynaptic N‐Methyl‐D‐Aspartate Receptors on Dopaminergic Nerve Terminals , 1991, Journal of neurochemistry.
[27] Effect of afferent brachial stimulation and photic stimulation on glycogen concentration in cortical brain tissue , 1990, Neurochemistry International.
[28] A. Gobert,et al. The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function , 1990, Neuroscience.
[29] Z. Rossetti,et al. NMDA receptor activation mediates glutamate and aspartate release from rat striatum: prevention by MK-801. , 1990 .
[30] A. Carlsson,et al. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.
[31] G. E. Alexander,et al. Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.
[32] J. Deniau,et al. Disinhibition as a basic process in the expression of striatal functions , 1990, Trends in Neurosciences.
[33] J. Desce,et al. Glutamate Receptors of a Quisqualate‐Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo , 1990, The European journal of neuroscience.
[34] G. Chiara. In-vivo brain dialysis of neurotransmitters , 1990 .
[35] U. Ungerstedt,et al. Anaesthesia effects on in vivo acetylcholine transmission; comparisons of radioenzymatic and HPLC assays. , 1990, European journal of pharmacology.
[36] S. Weiss. Pharmacological properties of the N-methyl-D-aspartate receptor system coupled to the evoked release of gamma-[3H] aminobutyric acid from striatal neurons in primary culture. , 1990, The Journal of pharmacology and experimental therapeutics.
[37] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[38] W. Schmidt,et al. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats , 1989, Pharmacology Biochemistry and Behavior.
[39] J. Bockaert,et al. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[40] D. Nicholls,et al. Presynaptic regulation of glutamate release from guinea-pig cortical synaptosomes , 1988 .
[41] C. Carter,et al. Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study , 1988, Journal of neurochemistry.
[42] S. Weiss. Excitatory Amino Acid‐Evoked Release of γ‐[3H]Aminobutyric Acid from Striatal Neurons in Primary Culture , 1988, Journal of neurochemistry.
[43] P. Stanzione,et al. Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro. , 1988, The Journal of physiology.
[44] N. Dusticier,et al. Comparative analysis of the effects of in vivo electrical stimulation of the frontal cortex and gamma-butyrolactone administration on dopamine and dihydroxyphenyl acetic acid (DOPAC) striatal contents in the rat , 1987, Neurochemistry International.
[45] R. Romo,et al. In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence ofl-glutamate , 1986, Neuroscience.
[46] K. Starke,et al. A Search for Receptors Modulating the Release of γ‐[3H]Aminobutyric Acid in Rabbit Caudate Nucleus Slices , 1986, Journal of neurochemistry.
[47] J. Deniau,et al. Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus , 1985, Brain Research.
[48] P. Herrling. Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: Evidence for its mediation by quisqualateor kainate-receptors , 1985, Neuroscience.
[49] M. Desban,et al. Local cerebral glucose consumption in the rat. II. Effects of unilateral substantia nigra stimulation in conscious and in halothane‐anesthetized animals , 1983, The Journal of comparative neurology.
[50] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[51] C. Gauchy,et al. Bilateral asymmetrical changes in the nigral release of [3H]GABA induced by unilateral application of acetylcholine in the cat caudate nucleus , 1982, Brain Research.
[52] B. Scatton,et al. N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids , 1982, Nature.
[53] B. Scatton,et al. Cortical modulation of striatal function , 1982, Brain Research.
[54] J. Mcculloch,et al. The effects of chloral hydrate anesthesia on the metabolic response in the substantia nigra to apomorphine , 1981, Brain Research.
[55] R. Mitchell. A novel GABA receptor modulates stimulus-induced glutamate release from cortico-striatal terminals. , 1980, European journal of pharmacology.
[56] P. Roberts,et al. STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS , 1979, Journal of neurochemistry.
[57] T. James,et al. The role of GABA in the substantia nigra , 1978, Nature.
[58] S. Snyder,et al. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.
[59] R. Roth,et al. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.